PFS by combined MH (metabolic heterogeneity) and TLG (total lesion glycolysis). Low risk (MH and TLG low); intermediate risk (either low MH and high TLG or high MH and low TLG); high risk (high MH and high TLG). Modified and reproduced from Ceriani et al.⁷⁵